Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Stage IIIC”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT02142803
What this trial is testing

TORC1/2 Inhibitor MLN0128 and Bevacizumab in Treating Patients With Recurrent Glioblastoma or Advanced Solid Tumors

Who this might be right for
Adult GlioblastomaEndometrial Clear Cell AdenocarcinomaEndometrial Serous Adenocarcinoma+21 more
National Cancer Institute (NCI) 50
Large-scale testing (Phase 3)Study completedNCT00438659
What this trial is testing

Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ

Who this might be right for
Breast CancerDermatologic ComplicationsRadiation Toxicity+1 more
North Central Cancer Treatment Group 176
Not applicableWithdrawnNCT01292083
What this trial is testing

Azacitidine in Treating Patients With Triple Negative Stage I-IV Invasive Breast Cancer That Can Be Removed By Surgery

Who this might be right for
Recurrent Breast CancerStage IA Breast CancerStage IB Breast Cancer+6 more
University of Southern California
Large-scale testing (Phase 3)Ended earlyNCT04427072
What this trial is testing

Study of Capmatinib Efficacy in Comparison With Docetaxel in Previously Treated Participants With Non-small Cell Lung Cancer Harboring MET Exon 14 Skipping Mutation

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Novartis Pharmaceuticals 22
Testing effectiveness (Phase 2)Ended earlyNCT02359851
What this trial is testing

Pembrolizumab in Treating Patients With Advanced Uveal Melanoma

Who this might be right for
Stage IIIA Uveal MelanomaStage IIIB Uveal MelanomaStage IIIC Uveal Melanoma+1 more
Vanderbilt-Ingram Cancer Center 5
Not applicableStudy completedNCT00719966
What this trial is testing

Effect of Aromatase Inhibitor Therapy on Blood Vessel Function in Postmenopausal Women With Breast Cancer

Who this might be right for
Breast Cancer
Mayo Clinic 109
Early research (Phase 1)Study completedNCT00562640
What this trial is testing

Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009)

Who this might be right for
Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
Memorial Sloan Kettering Cancer Center 12
Not applicableStudy completedNCT00363012
What this trial is testing

Immune Response in Patients Who Have Undergone Vaccine Therapy for Stage III or Stage IV Breast Cancer That Overexpresses HER2

Who this might be right for
Breast Cancer
University of Washington 56
Not applicableUnknownNCT00450593
What this trial is testing

Identifying Gene Mutations in Patients With Melanoma and in Families With a History of Hereditary Melanoma

Who this might be right for
Hereditary Multiple MelanomaMelanoma (Skin)
Leeds Cancer Centre at St. James's University Hospital 5,000
Testing effectiveness (Phase 2)Study completedNCT01840007
What this trial is testing

Pilot Study Evaluating the Efficacy and Safety of Metformin in Melanoma

Who this might be right for
Metastatic Melanoma (Stage IIIC Non-résécable or no Surgically Curable or Stage IV With Classification AJCC)
Centre Hospitalier Universitaire de Nice 20
Early research (Phase 1)Study completedNCT01638533
What this trial is testing

Romidepsin in Treating Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Solid Tumors With Liver Dysfunction

Who this might be right for
GliomaHematopoietic and Lymphoid Cell NeoplasmLymphoma+47 more
National Cancer Institute (NCI) 37
Very early researchStudy completedNCT00331630
What this trial is testing

Abraxane and Lapatinib in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Northwestern University 30
Not applicableStudy completedNCT04183218
What this trial is testing

Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes

Who this might be right for
Clinical Stage 0 Esophageal Adenocarcinoma AJCC v8Clinical Stage 0 Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage I Esophageal Adenocarcinoma AJCC v8+53 more
Mayo Clinic 24
Testing effectiveness (Phase 2)UnknownNCT00398489
What this trial is testing

Docetaxel, Epirubicin, and Cyclophosphamide With or Without Trastuzumab in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery

Who this might be right for
Breast Cancer
Technical University of Munich 94
Very early researchEnded earlyNCT00499733
What this trial is testing

Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial Cancer

Who this might be right for
Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)WithdrawnNCT03735589
What this trial is testing

Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Who this might be right for
Stage II Fallopian Tube Cancer AJCC v8Stage II Ovarian Cancer AJCC v8Stage II Primary Peritoneal Cancer AJCC v8+31 more
Roswell Park Cancer Institute
Testing effectiveness (Phase 2)Study completedNCT02574260
What this trial is testing

An Extension Protocol for the Extended Use of Talimogene Laherparepvec for Eligible Patients Who Participated in Study 002/03 (NCT00289016)

Who this might be right for
Melanoma
BioVex Limited 3
Testing effectiveness (Phase 2)UnknownNCT00083018
What this trial is testing

Nipple Aspiration, Ductal Lavage, and Duct Endoscopy For Diagnostic Assessment in Women Undergoing Surgery for Breast Cancer

Who this might be right for
Breast Cancer
Royal Marsden NHS Foundation Trust 100
Not applicableUnknownNCT00309920
What this trial is testing

Combination Chemotherapy With or Without Darbepoetin Alfa in Treating Women With Stage III Breast Cancer

Who this might be right for
Breast Cancer
Heinrich-Heine University, Duesseldorf 1,234
Not applicableStudy completedNCT00489125
What this trial is testing

Strength and Range of Motion in Women Undergoing Surgery for Breast Cancer

Who this might be right for
Breast Cancer
Wake Forest University Health Sciences 400
Next Page